The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Huperzine A decreased intracellular Aβ₄₂ accumulation. by Yun Lei (495070)

Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

hESCs-CM decreased cancer cells growth. by Shufeng Zhou (398572)

Subjects:

Tax expression is associated with decreased cellular motility. by Saumya Ramanayake (7879091)

Running increased neural stem cell proliferation in the dentate gyrus, but did not decrease inflammation. by Kaja Falkenhain (9317016)

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

Means for STEM competence for pre- and post-test. by Esther Kim (2996622)

Subjects:

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

Inducible and conditional knockout (icKO) of ERK5 decreases adult OB neurogenesis. by Tan Li (404990)

Subjects:

RAC1 inhibition results in a decrease in oxidative phosphorylation. by Shruthi Sriramkumar (12705564)

Repetitive stress induces a decrease in sound-evoked activity. by Ghattas Bisharat (20706928)

“…These mice exhibited a minimal change in noise-evoked PPy activity when comparing the first and second week of imaging (2-way ANOVA, F = 1.79, <i>p</i> = 0.11, post hoc baseline w1 50 dB: baseline w2 50 dB <i>p</i> = 1 Bonferroni corrected, nested ANOVA (mouse nested within session) F = 1.76, <i>p</i> = 0.12, mean ± SE). …”

Decreased ISCs and increased goblet cells after intestinal specific loss of MLL1. by Neha Goveas (11790822)

“…(C) Decrease in ISC markers, OLFM4 and SOX9 in <i>Mll1</i>^{<i>FC/FC; Vil-Cre-ERT2/+</i>} intestinal sections. …”

Identification of proteins that presented a significant decrease in their expression content. by Rubens D. M. Magalhães (395962)

FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma. by Laura L. Stafman (6577184)

“…The mean ± SEM for each treatment group were calculated and depicted in a bar graph. …”

Calpeptin treatment decreases cell density and proliferation. by Daniela M. Santos (211055)

FTY720 decreased viability, proliferation, and motility and induced apoptosis in human hepatoblastoma cells. by Laura L. Stafman (6577184)

“…<p>(A) Following 24 hours of treatment with FTY720, the viability of HuH6 cells measured using the alamarBlue cell viability assay was significantly decreased (LD₅₀ = 8.4 μM, p ≤ 0.05). …”

<i>Kdm6a</i> conditional KO mice have decreased repopulating potential in serial competitive transplantation assays. by Ling Tian (107492)

“…(C) Quantification of donor cell chimerism in hematopoietic stem cells (HSCs) in BM by flow cytometry 36 weeks after transplantation. …”

Decreased lung tissue neutrophil infiltration in fCB-CD34⁺ cell-treated mice. by Xiaojia Huang (298132)